Accurx
PrivateLast Round
Series B
Sep 15, 2021
Est. Valuation
$457.73M
Total Funding Raised
$50.41M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Accurx is a healthcare technology company that provides a communication platform for medical professionals to engage with patients through appointment booking, patient questionnaires, online consultations, and video consultations.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Patient Engagement, EHR & EMR, NLP & Conversational AI
Business Model
B2B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accurx Comparables
Compare Accurx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DrDoctor | 82% | |
| OneAdvanced | 82% | |
| Anima | 79% |
Accurx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 15, 2021 | ||||
| Series A | Feb 24, 2019 | ||||
| Seed | Mar 17, 2017 | ||||
| Accelerator | Sep 6, 2016 |
Accurx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anvil Partners | Seed |
| Trusted Insight | Series B |
| Latitude Ventures | Series B |
| Encore Capital | Series B |
| British Patient Capital | Series B |
| Lakestar | Series B |
| Phoenix Court Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Works with 41 of the 42 NHS Integrated Care Boards in primary care.
- Jun 22, 2026
Launched Accurx Scribe, an AI-powered real-time medical note-taker.
Recent news
Latest coverage and updates
- signs_new_clientAug 2, 2026
In Mar '26, Accurx signs a three-year contract with HCT Partnership for ambient voice technology across more than 1,000 clinicians in United Kingdom.
Accurx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Accurx's valuation, stock price, and market status.
Is Accurx a public or private company?
Accurx is a private company.
What is the current stock price of Accurx?
Accurx is a private company, so its shares have no public market price. Caplight tracks Accurx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Accurx worth (valuation)?
Accurx's valuation is estimated at $457.7M based on funding round data.
Can I buy Accurx stock?
Accurx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Accurx's last funding round?
Accurx's most recent funding round was Series B on September 15, 2021.
Who are the main investors in Accurx?
Key investors in Accurx include Lakestar, Atomico.
Will Accurx IPO soon?
No public IPO plans have been announced for Accurx.
How can I track Accurx secondary market activity?
Caplight tracks bids, offers, and trades in Accurx's shares on secondary markets.